GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Pharmalabs Ltd (BOM:543748) » Definitions » Receivables Turnover

Aarti Pharmalabs (BOM:543748) Receivables Turnover : 0.98 (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Aarti Pharmalabs Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Aarti Pharmalabs's Revenue for the three months ended in Mar. 2025 was ₹5,638 Mil. Aarti Pharmalabs's average Accounts Receivable for the three months ended in Mar. 2025 was ₹5,754 Mil. Hence, Aarti Pharmalabs's Receivables Turnover for the three months ended in Mar. 2025 was 0.98.


Aarti Pharmalabs Receivables Turnover Historical Data

The historical data trend for Aarti Pharmalabs's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Pharmalabs Receivables Turnover Chart

Aarti Pharmalabs Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Receivables Turnover
- 3.16 4.68 3.82 3.86

Aarti Pharmalabs Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 1.07 1.06 1.24 0.98

Competitive Comparison of Aarti Pharmalabs's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Pharmalabs's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarti Pharmalabs's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Pharmalabs's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Aarti Pharmalabs's Receivables Turnover falls into.


;
;

Aarti Pharmalabs Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Aarti Pharmalabs's Receivables Turnover for the fiscal year that ended in Mar. 2025 is calculated as

Receivables Turnover (A: Mar. 2025 )
=Revenue / Average Total Inventories
=Revenue (A: Mar. 2025 ) / ((Accounts Receivable (A: Mar. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count )
=21150.745 / ((5193.444 + 5754.047) / 2 )
=21150.745 / 5473.7455
=3.86

Aarti Pharmalabs's Receivables Turnover for the quarter that ended in Mar. 2025 is calculated as

Receivables Turnover (Q: Mar. 2025 )
=Revenue / Average Total Inventories
=Revenue (Q: Mar. 2025 ) / ((Accounts Receivable (Q: Dec. 2024 ) + Accounts Receivable (Q: Mar. 2025 )) / count )
=5637.77 / ((0 + 5754.047) / 1 )
=5637.77 / 5754.047
=0.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarti Pharmalabs  (BOM:543748) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Aarti Pharmalabs Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Aarti Pharmalabs's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Pharmalabs Business Description

Traded in Other Exchanges
Address
Mulund Goregaon Link Road, 2nd floor, 204, Udyog Kshetra, Mulund West, Mumbai, MH, IND, 400080
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, and xanthine derivatives in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.

Aarti Pharmalabs Headlines

No Headlines